RxAdjacent Labs

Methodology & evidence

We show our work.

Our programs are built from published guidelines and peer-reviewed research, and we measure every cohort against pre-declared outcomes. Here is what we rely on — and what we don’t claim.

Why this matters: prevalence

47.7%[CDC]

of U.S. adults have hypertension

~1 in 5[CDC]

adults with hypertension are at goal (<130/80)

31%[WHO]

of adults worldwide don’t meet activity guidelines

What the research says about activity and blood pressure

Figures below are from published studies of populations. They describe research findings, not results any individual should expect from our product.

Aerobic activity

~4–7 / 3–4 mmHg[2025]

Average BP difference in study populations cited in the 2025 AHA/ACC guideline (not a prediction for you), which recommends ≥150 min/week of moderate aerobic activity.

Isometric training

8.24 / 4.00 mmHg[Edwards]

Pooled resting BP difference across 270 RCTs (15,827 participants). Wall squat showed the largest systolic difference. Typical protocol: 4 × 2-min holds, 3×/week.

Daily steps

6–8k / day[Paluch]

Where mortality risk associations plateaued for adults 60+ (8–10k for younger adults). Biggest differences at the low end.

Activity trackers

+~1,800 steps[Ferguson]

Average daily increase associated with wearable-based interventions.

Self-efficacy

7 of 9 reviews[Choi][Frontiers]

Most consistent personal correlate of physical activity. Home-exercise adherence OR 1.58.

Habit formation

66 days median[Lally]

Time to automaticity; a missed day did not derail habit formation.

How we design

  1. 01

    Screen first

    ACSM-style pre-participation questions route people to “start light” or “check with your clinician first”.

  2. 02

    Build confidence before intensity

    Mastery experiences in weeks 1–2, mapped to the COM-B model (capability, opportunity, motivation).

  3. 03

    Dose ladder

    Level 1 sitting breaks + short walks → Level 2 anchor routine (isometrics) → Level 3 ~150 min/week. Progress only after completed, comfortable sessions.

  4. 04

    Measure simply

    Steps, 30-second chair stand, home readings with validated-cuff guidance, and confidence.

  5. 05

    Expect attrition, design re-entry

    Digital health has a structural “law of attrition”; we plan restart paths instead of punishing streaks.

Our dose ladder is an internal synthesis of the evidence, not a validated clinical protocol.[Michie][Eysenbach]

Outcomes we measure

Pre-declared for every pilot cohort. We will publish results, including null results.

Week-1 completionTarget > 70% of enrolled users
Week-4 active retentionSurvival curve by cohort
Confidence ratingChange from baseline, 1–10
Ladder progression% reaching level 2 (anchor routine)
Home BP trendChange in 7-day systolic average, weeks 8–12 (descriptive)
Chair standChange in 30-second count
SafetyAll adverse events and flagged readings, reported
Care-team sharing% of users sharing a clinician summary

Pilot results: First cohort launching soon.

What we don’t claim

  • — Our tools do not diagnose, treat, cure, or prevent any disease.
  • — We never recommend starting, stopping, or changing a medication.
  • — Research findings above are not a promise of individual results.
  • — Clinician summaries display trends; interpretation is the clinician’s.

Positioned under FDA’s general wellness policy.[FDA]

Sources

RxAdjacent Labs tools are general wellness products designed to support physical activity and self-tracking. They are not medical devices, do not diagnose, treat, or cure any condition, and never recommend changes to medication. Talk with your clinician before starting a new activity program and before making any change to your medications.